Healthtech Startup Watch Your Health Marks Final Close Of Series A Round At $5 Mn

Mumbai-based B2B healthtech platform Watch Your Health has marked the final close of its Series A round at $5 Mn after raising capital from Cornerstone Ventures from India and Conquest Global from Singapore.

The company will use the fresh funds to scale up its operations, expand user base, as well as to boost technological infrastructure and platform capabilities.

Founded in 2015, Watch Your Health helps insurance and pharma companies improve their customer apps. Its platform supports the consumer apps of major insurers and pharmaceutical companies by adding health tracking, guidance on diet and exercise management, and advanced analytics for personalised tips. 

The startup counts ICICI Lombard General Insurance, Kotak Life Insurance, Reliance General Insurance, Dr. Lal PathLabs, Madhavbaug Multidisciplinary Cardiac Care Clinics & Hospitals and Zydus Cadila among its portfolio clients.

Ratheesh Nair, co-founder at Watch Your Health, said, “This will enable us to improve our technological infrastructure, expand our user base, and introduce innovative health management solutions.”

Nanika Kakkar, partner, Cornerstone Ventures, said “What we like the best about the platform is the ease with which it is able to attribute the value it is creating for its clients and that impact is telling and consistent – leading to a value-share driven business model. We believe this simply takes the potential of the platform to a completely different level.”

Watch Your Health has partnered with several leading healthcare providers to integrate their services into the Watch Your Health platform. Notable partnerships include Watania Takaful and Shalina Healthcare in the UAE, marking a significant step in international market expansion.

The startup’s new investment comes a year after it raised $2.2 Mn from Conquest Global Ventures.

In 2024 the digital health market in India is worth about INR 73,873 Cr (USD 8.8 Bn) and is expected to grow by about 17.67% each year from 2024 to 2033 to reach around INR 4,01,578 Cr (USD 47.8 Bn) by 2033.

The company competes against the likes of MyKare, HealthifyMe, Practo, CureFit and 1mg.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.